Radicle ACES: A Study of Commercially Available CBD Used in the Real-world Setting

A Randomized, Open-label Study of Commercially Available, Orally Ingestible, Cannabidiol (CBD) Products Used in the Real-world Setting for Pain, Sleep, and Anxiety

A randomized, open-label study of commercially available, orally ingestible, Cannabidiol (CBD) products used in the real-world setting for pain, sleep, and anxiety.

Radicle ACES is a real-world evidence study that aims to determine the effect of CBD on overall well-being, anxiety, sleep, and pain over a 28-day period in treatment groups compared to a waitlist control group.

Inclusion Criteria:

• Participants must be 21 years of age
• Live in the USA
• Endorse symptoms of anxiety, chronic pain, or sleep disturbances as a primary reason for taking a CBD product
• Must have regular access to a computer, mobile device, and/or the internet to complete surveys

Exclusion Criteria:

• A person pregnant, trying to become pregnant or breastfeeding
• Anyone diagnosed with liver disease or considered a heavy drinker
• Anyone taking medication that warns against grapefruit consumption